Press Release Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe Aug 20
Press Release Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology Aug 4
Press Release Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026 Jul 30